Skip to content

Evaluation of Safety and Efficacy of Using Venus Freeze™ (MP)2 V2 System for Wrinkles Rhytides and Cellulite Treatment

Evaluation of Safety and Efficacy of Using Venus Freeze™ (MP)2 V2 System for Wrinkles Rhytides and Cellulite Treatment - a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01234259
Enrollment
60
Registered
2010-11-04
Start date
2010-12-31
Completion date
2014-09-30
Last updated
2020-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circumference Reduction, Wrinkled Structure

Keywords

Wrinkles, rhytides, Cellulite, circumference reduction

Brief summary

Skin aging is a multifactorial process involving the 3 layers of the skin: Epidermis, dermis and hypodermis. Radio-frequency (RF) devices have been used for many years for a variety of surgical applications. The energy delivery systems of these established monopolar devices used a 'conductive coupling' delivery system in which energy is concentrated at the periphery of the electrode. Venus Concept has developed the Venus Freeze (MP)2 V2 system for wrinkles, rhytides and temporary cellulite and circumference reduction treatments. While treating wrinkles rhytides and cellulite, the treatments creates enough thermal effect to induce collagen remodeling with no ablative thermal damage in the epidermis or dermis.

Interventions

DEVICEVenus Freeze (MP2 V2 System

Facial wrinkles and temporary cellulite and circumference reduction treatments

Sponsors

Venus Concept
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy males and females age 30 and up * Subjects with Fitzpatrick 4 to 9 degrees of elastosis * Subject able to comprehend and give informed consent for participation in this study * Subject must commit to all treatments and follow-up visits * Subject must sign the Informed Consent Form

Exclusion criteria

* Subjects with implanted pacemakers, arrhythmias or any other severe known heart disorder * Subjects with any implantable metal device in the treatment area * Subjects on any medication that would affect the characteristic of the skin (medical or hormonal), such as Accutane, within the past 6 months or photosensitizing medications * Subjects that have had any other invasive or non invasive method of skin therapy or hair removal performed in the past 9 months (in the treated area) Subjects who are scheduled or planned for any other invasive or non invasive method of skin therapy or hair removal in the treated area at the period of the study * Subjects who have any form of malignant skin cancer on the treatment area * Subjects with history of keloid formations or hypertrophic scarring * Pregnant or lactating Subjects * Subjects with Epilepsy or severe migraines * Subjects with permanent makeup/ tattoo/ body piercing (in the treated area) * Subjects with any Infection / abscess / dermatitis/ pains in treatment target area. * Subjects who suffer from autoimmune disorders or diabetes * Subjects with clotting disorders * Subjects are suffering from psychiatric disorders and treated with psychiatric medications. * Subject is suffering extreme general weakness. * Subject objects to the study protocol * Concurrent participation in any other clinical study * Physician objection

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the efficacy of the Venus system for wrinkles rhytides and temporary cellulite and circumference reduction treatment. Efficacy evaluation will include RF, Magnetic Pulse Field and vacuum technology.5 monthsEfficacy will be established by skin improvement as a result of the treatment by validated scales. Results will be compared to control group results. The pre - and post-treatment photographs will be compared and assessed by three independent dermatologists.

Secondary

MeasureTime frameDescription
To evaluate the safety of the Venus Freeze (MP)2 V2 system for wrinkles, rhytides, temporary cellulite and circumference reduction. Safety evaluation will include RF, Magnetic Pulse Field and vacuum technology.5 monthsSafety parameters will include adverse events (signs of pain; edema; burn; localized infection; skin pigmentation & texture alterations) occurring as a direct result of the treatment and complaints up to last follow up visit.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026